These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6424474)

  • 1. Long-term reversible contraception with levonorgestrel-releasing Silastic rods.
    Roy S; Mishell DR; Robertson DN; Krauss RM; Lacarra M; Duda MJ
    Am J Obstet Gynecol; 1984 Apr; 148(7):1006-13. PubMed ID: 6424474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First year clinical experience with six levonorgestrel rods as subdermal contraception.
    Faundes A; Brache de Mejias V; Leon P; Robertson D; Alvarez F
    Contraception; 1979 Aug; 20(2):167-75. PubMed ID: 487818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norplant contraceptive implants: rods versus capsules.
    Pasquale SA; Brandeis V; Cruz RI; Kelly S; Sweeney M
    Contraception; 1987 Sep; 36(3):305-16. PubMed ID: 3119287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levonorgestrel and progesterone levels in women treated with silastic covered rods containing levonorgestrel.
    Croxatto HB; Díaz S; Brandeis A; Pavez M; Johansson ED
    Contraception; 1985 Jun; 31(6):643-54. PubMed ID: 3930143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and endocrinologic study of continuous levonorgestrel administration from subcutaneous solid polydimethylsiloxane rods.
    Roy S; Stanczyk F; Mishell DR; Lumkin M; Gentzschein E
    Contraception; 1980 Jun; 21(6):595-615. PubMed ID: 6775868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release rates of levonorgestrel from Silastic capsules, homogeneous rods and covered rods in humans.
    Robertson DN; Sivin I; Nash HA; Braun J; Dinh J
    Contraception; 1983 May; 27(5):483-95. PubMed ID: 6411428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A five-year clinical trial of levonorgestrel silastic implants (Norplant TM).
    Diaz S; Pavez M; Miranda P; Robertson DN; Sivin I; Croxatto HB
    Contraception; 1982 May; 25(5):447-56. PubMed ID: 6809423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonorgestrel plasma levels during continuous administration with different models of subdermal implants.
    Alvarez F; Brache V; Faundes A; Johansson ED; Odlind V; Nash H
    Contraception; 1983 Feb; 27(2):123-30. PubMed ID: 6406138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subdermal progestin implant contraception.
    Darney PD
    Curr Opin Obstet Gynecol; 1991 Aug; 3(4):470-6. PubMed ID: 1908716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new delivery system for contraceptive steroids.
    Segal S
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1090-2. PubMed ID: 3118719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonic visualization of NORPLANT subdermal contraceptive devices.
    Thomsen RJ; Pasquale S; Nosher J
    Int J Gynaecol Obstet; 1985 Jun; 23(3):223-7. PubMed ID: 2865186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
    Olsson SE; Odlind V; Johansson ED; Nordström ML
    Contraception; 1987 Mar; 35(3):215-28. PubMed ID: 3111784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal implants: contraception for a new century.
    Darney PD
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II randomized comparative clinical trial of Norplant (six capsules) with Norplant-2 (two covered rods) subdermal implants for long-term contraception: report of a 24-month study. National Programme of Research in Human Reproduction.
    Hingorani V; Jalnawala SF; Kochhar M; Rai Chaudhury G; Sengupta PC; Datey S; Mehta S; Roy M; Saxena NC; Saxena BN
    Contraception; 1986 Mar; 33(3):233-44. PubMed ID: 3087694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
    Olsson SE
    Acta Obstet Gynecol Scand Suppl; 1987; 142():1-45. PubMed ID: 3116821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of continuous levonorgestrel treatment (subcutaneous capsules) on the lipoprotein and carbohydrate metabolism in fertile women.
    Lithell H; Weiner E; Vessby B; Johansson ED
    Ups J Med Sci; 1983; 88(2):103-8. PubMed ID: 6417867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraception with long-acting subdermal implants. A five-year clinical trial with Silastic covered rod implants containing levonorgestrel. The International Committee for Contraception Research (ICCR) of the Population Council.
    Robertson DN; Diaz S; Alvarez-Sanchez F; Holma P; Mishell DR; Coutinho E; Brache V; Croxatto HB; Faundes A; Lacarra M
    Contraception; 1985 Apr; 31(4):351-9. PubMed ID: 3924476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norplant: subdermal implant system for long-term contraception.
    Shoupe D; Mishell DR
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1286-92. PubMed ID: 2497646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.